# CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs

> **NCT06565546** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 100 (estimated)

## Conditions studied

- Ventral Hernia

## Interventions

- **OTHER:** Opioid pain medication prescribed based on CYP2D6 genotype testing PLUS Acetaminophen and Gabapentin
- **OTHER:** Acetaminophen and Gabapentin: standard postoperative pain medications

## Key facts

- **NCT ID:** NCT06565546
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-29
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06565546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06565546, "CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06565546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*